OMAHA, Nebraska (September 5, 2023)—UNeMed, a technology commercialization office for the University of Nebraska, announced today that Alexi Wellman will join its Board of Directors.
A Papillion native, Wellman is the CEO of Altaba, Inc., a closed-end investment fund; serves on several boards, including Werner Enterprises and ESS, Inc.; and is a venture partner and investment committee member at SpringTide Ventures, an investment firm focused on supporting healthcare related startups, as well as, an investment committee member of Move Venture Capital, an early stage capital source for Nebraska founders.
“We are beyond thrilled to add Alexi to our Board,” Chairperson Anne Barnes said. “Her expertise and support for high-growth startups is well known, and will be a massive boost for our University entrepreneurs. UNeMed, and by extension all of UNMC and UNO inventors will benefit from this addition.”
Prior to joining Altaba, Wellman was a vice president and global controller at Yahoo!, served as Chief Financial Officer of the Nebraska Book Company, Inc., and was partner with KPMG.
More recently, Wellman received the University of Nebraska-Kearney College of Business and Technology Distinguished Alumna Award. A licensed certified public accountant, she graduated from UNK with a bachelor’s degree in business administration in 1992.
Wellman also volunteers to help under-served youth in the city while working with Abide Omaha, a program that aims to revitalize the inner-city, and also coaching the Bryan High girls basketball team.
UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center and the University of Nebraska at Omaha. UNeMed serves all UNMC and UNO researchers, faculty and staff who develop new technologies and inventions, and strives to help bring those innovations to the marketplace.